The effects of salmeterol/fluticasone on circulating biomarker in stable chronic obstructive pulmonary disease.
Phase of Trial: Phase IV
Latest Information Update: 21 May 2012
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Salbutamol/ipratropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Biomarker; Pharmacodynamics
- 17 Jul 2009 New trial record.